HIV molecular immunology database
Found 3 matching records:
HXB2 Location | Gag(77-85) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
SLYNTVATL
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Species (MHC/HLA) | human(A2) |
Showing all: 2 variant(s).
Variant ID. | 500 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLfNTVATL |
Mutations | Y/F |
Epitope Location | Y3F |
HXB2 Location | Y79F |
Mutation Type | OV: observed variant |
Note | Two of the subjects carried this variant of the epitope |
Variant ID. | 501 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLYNTiATL |
Mutations | V/I |
Epitope Location | V6I |
HXB2 Location | V82I |
Mutation Type | OV: observed variant |
Note | One of the subjects carried this variant of the epitope. |
Jansen2005a Christine A. Jansen, Stefan Kostense, Kristin Vandenberghe, Nening M. Nanlohy, Iris M. De Cuyper, Erwan Piriou, Erik H. Manting, Frank Miedema, and Debbie van Baarle. High Responsiveness of HLA-B57-Restricted Gag-Specific CD8+ T Cells In Vitro May Contribute to the Protective Effect of HLA-B57 in HIV-Infection. Eur. J. Immunol., 35(1):150-158, Jan 2005. PubMed ID: 15593302. Show all entries for this paper.
HXB2 Location | Gag(162-172) | Gag Epitope Map
View variants at this location |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KAFSPEVIPMF
|
Epitope Alignment | ||||||||||
Variants |
|
|||||||||||
Epitope Name | KAF | |||||||||||
Species (MHC/HLA) | human(B57) |
Showing all: 3 variant(s).
Variant ID. | 502 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KvFSPEVIPMF |
Mutations | A/V |
Epitope Location | A2V |
HXB2 Location | A163V |
Mutation Type | OV: observed variant |
Note | Variant was found in 2/5 B57+ individuals, but was always in a minor form. The frequency of the epitope mutation did not correlate with the percentage of IFN-gamma producing CTLs. |
Variant ID. | 503 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | eAFSPEVIPMF |
Mutations | K/E |
Epitope Location | K1E |
HXB2 Location | K162E |
Mutation Type | OV: observed variant |
Note | Variant was found in 1/5 B57+ individuals, but was always in a minor form. The frequency of the epitope mutation did not correlate with the percentage of IFN-gamma producing CTLs. |
Variant ID. | 504 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KtFSPEVIPMF |
Mutations | A/T |
Epitope Location | A2T |
HXB2 Location | A163T |
Mutation Type | OV: observed variant |
Note | Variant was found in 1/5 B57+ individuals, but was always in a minor form. The frequency of the epitope mutation did not correlate with the percentage of IFN-gamma producing CTLs. |
Jansen2005a Christine A. Jansen, Stefan Kostense, Kristin Vandenberghe, Nening M. Nanlohy, Iris M. De Cuyper, Erwan Piriou, Erik H. Manting, Frank Miedema, and Debbie van Baarle. High Responsiveness of HLA-B57-Restricted Gag-Specific CD8+ T Cells In Vitro May Contribute to the Protective Effect of HLA-B57 in HIV-Infection. Eur. J. Immunol., 35(1):150-158, Jan 2005. PubMed ID: 15593302. Show all entries for this paper.
HXB2 Location | Gag(260-267) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
EIYRKWII
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Species (MHC/HLA) | human(B8) |
Showing all: 2 variant(s).
Variant ID. | 505 |
---|---|
Epitope Seq. | EIYRKWII |
Variant Seq. | EfYRKWII |
Mutations | I/F |
Epitope Location | I2F |
HXB2 Location | I261F |
Mutation Type | OV: observed variant |
Note | Variant was found in 1/5 B57+ individuals, but was always in a minor form. The frequency of the epitope mutation did not correlate with the percentage of IFN-gamma producing CTLs. |
Variant ID. | 506 |
---|---|
Epitope Seq. | EIYRKWII |
Variant Seq. | rIYRKWII |
Mutations | E/R |
Epitope Location | E1R |
HXB2 Location | E260R |
Mutation Type | OV: observed variant |
Note | Variant was found in 1/5 B57+ individuals, but was always in a minor form. The frequency of the epitope mutation did not correlate with the percentage of IFN-gamma producing CTLs. |
Jansen2005a Christine A. Jansen, Stefan Kostense, Kristin Vandenberghe, Nening M. Nanlohy, Iris M. De Cuyper, Erwan Piriou, Erik H. Manting, Frank Miedema, and Debbie van Baarle. High Responsiveness of HLA-B57-Restricted Gag-Specific CD8+ T Cells In Vitro May Contribute to the Protective Effect of HLA-B57 in HIV-Infection. Eur. J. Immunol., 35(1):150-158, Jan 2005. PubMed ID: 15593302. Show all entries for this paper.